- Home
- / Tremeau Pharmaceuticals
Tremeau Pharmaceuticals
Total Funding
$5.2 M
Tremeau Pharmaceuticals Summary
Company Summary
- Overview
- Tremeau Pharmaceuticals is a company developing non-opioid pain therapies for rare diseases. It provides TRM-201, a product for the treatment of hemophilic arthropathy (HA). The company also develops TRM - 359 for the treatment of unmet needs in pain management in rare diseases.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Concord, MA, US | view all locations
- Website
- https://www.tremeaurx.com/
- Cybersecurity rating
Table of Contents
Key People
Judith Boice, Chief Development Officer
LocationsView all
1 location detected
Concord, MA HQ
United States
53 Main St #202